Gelomics
Suggest an EditAbout Gelomics
Gelomics accelerates drug development and biomedical research by enabling the cultivation of human tissues in petri dishes, offering an ethical and more predictive alternative to animal testing.
Gelomics accelerates drug development and biomedical research by enabling the cultivation of human tissues in petri dishes, offering an ethical and more predictive alternative to animal testing.
Company Highlights
Employees
YoY Headcount Growth
Year Founded
2018
Employees18
Location (HQ)
AUS
Last Funding Round
Pre Seed
YoY Headcount Growth196.72%
Key Metrics
Senior Hires
| Name | Linkedin Profile | Position | Date Joined |
|---|---|---|---|
| John Doe | https://www.linkedin.com/in/johndoe | CEO | CEO |
| Jane Doe | https://www.linkedin.com/in/janedoe | CTO | CTO |
| John Smith | https://www.linkedin.com/in/johnsmith | CFO | CFO |
| Jane Smith | https://www.linkedin.com/in/janesmith | COO | COO |
Biotechnology Research
- Tryp TherapeuticsNourish IngredientsEnGeneICEugeneNoxopharmCartherics Pty LtdMedicines Development for Global HealthClinialsLixaAdvanCellOptheaGPN VaccinesGenetic TechnologiesFerronovaRedenlabDiag-Nose.ioAll G FoodsAntisense TherapeuticsNeuren PharmaceuticalsImplicit BioscienceMinomic International LtdTetratherixProto AxiomEcofibreBionomicsProvectus AlgaePsyloPolyActivaCarina BiotechNumber 8 bioPhantmImmutepMaverick BioEpichemBiomeBankAtmo BiosciencesMISTIMIcrobioEpiminderHydGene RenewablesArovella Therapeutics ASX: ALAImmVirXIncisive TechnologiesRadiopharm TheranosticsImmuronOptalertVetChipKazia Therapeutics